Cleavable Linkers to Enhance Selectivity of Antibody-Targeted Therapy of Cancer-Reference-Cited by-同舟云学术

Cleavable Linkers to Enhance Selectivity of Antibody-Targeted Therapy of Cancer

Published:2001-12 Issue:6 Volume:16 Page:457-467
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Kukis David L.¹,Novak-Hofer Ilse²,DeNardo Sally J.³

Affiliation:

1. Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA, USA; dlkukis@ucdavis.edu

2. Center for Radiopharmaceutical Science ETH-PSI-USZ, Paul Scherrer Institute, CH-5232 Villigen, Switzerland

3. Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA, USA

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10849780152752065

Reference38 articles.

1. Continuous cultures of fused cells secreting antibody of predefined specificity

2. Structure and properties of pharmacologically active polymers

3. Assessment of the Radiochemical Design of Antibodies with a Metabolizable Linkage for Target-Selective Radioactivity Delivery

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease‐activated prodrugs: strategies, challenges, and future directions;The FEBS Journal;2020-02-26

2. An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine-Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker;Bioconjugate Chemistry;2018-11-01

3. 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: Synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model;Nuclear Medicine and Biology;2013-07

4. Sustained and cancer cell targeted cytosolic delivery of Onconase results in potent antitumor effects;Journal of Controlled Release;2012-05

5. Immunoconjugates Against Solid Tumors: Mind the Gap;Clinical Pharmacology & Therapeutics;2011-03-02